| Molecular formula | C28H35N5O4 |
|---|
| Molecular weight | 505.6 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 216208 |
|---|
What Capromorelin Is
Capromorelin is a synthetic small molecule with the chemical formula C28H35N5O4 and a molecular weight of about 505.6 g/mol (PubChem CID 216208). Beyond its chemical identity, this overview does not include label-based indication, mechanism, or side effect data, since that information was not provided in the source dataset used to generate this page.
What The Evidence Shows
No registered clinical trials or trial samples were available in the dataset used to compile this overview, so trial footprint details cannot be summarized here.
FAQ
Capromorelin is a synthetic small molecule identified by PubChem CID 216208, with a molecular formula of C28H35N5O4 and a molecular weight of roughly 505.6 g/mol. Detailed label information about its approved uses or mechanism was not available in the dataset used for this overview.
This overview is based on data marked as approved status, though specific label details such as indications and mechanism were not provided in the source dataset. Readers should consult official prescribing information for confirmed regulatory details.
The dataset used for this overview did not list any registered clinical trials or trial samples for capromorelin. As a result, no trial-based evidence summary can be provided here.
No adverse event report data was available in the dataset used to compile this overview, so a side effect summary cannot be provided at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 216208
Updated 2026-08-10